Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease is a research paper published in Biomolecules (2023). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK121797
National Institutes of Health
Grant: R01DK126884
National Institutes of Health
Grant: K01HL125445
National Institutes of Health
Grant: P01HL05197
National Institutes of Health
Grant: P20GM104357
National Institutes of Health
Grant: P30 GM127211
BLRD VA
Grant: I01 BX004671
National Institutes of Health
Grant: 4P20GM104357-04
Cadiorenal and Metabolic Diseases Research Center
National Institutes of Health
Grant: 5P30GM127211-05
Center of Research on Obesity and Cardiovascular Disease
National Institutes of Health
Grant: 1K01HL125445-01
Antioxidant-PPARalpha interaction and hypertension
National Institutes of Health
Grant: 7R01DK121797-02
Novel Liver Signaling Pathways Controlling Adiposity
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals